Clinical Trial Update: Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on the immunologic basis of anti-IgE therapy in patients with asthma and related allergic conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma
• Atopic Dermatitis

Drugs mentioned

• Anti-IgE therapy

Snippet

Sponsor: University of California, Davis | Conditions: Asthma, Allergic Rhinitis | Phase 4 | Status: COMPLETED | Results posted: 2021-07-13